돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 13140생성일: 2026년 10월 24일

Butyronitrile → Methyl 4-{5-[(1R,2S)-2-amino-1-phenylpropoxy]-1H-indazole-1-yl}benzoate

https://huagongshe.com/ko/reaction/13140

반응식

참여 물질

역할이름HCID투입량
반응물ButyronitrileHCID 8008—
반응물PhenylpropanolamineHCID 10297—
반응물Cesium carbonateHCID 10796—
반응물Methyl-4-(5-iodoindazole-1-yl)-benzoateHCID 66812731—
촉매Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)HCID 24350—
생성물Methyl 4-{5-[(1R,2S)-2-amino-1-phenylpropoxy]-1H-indazole-1-yl}benzoateHCID 6681270316.4%

반응 단계

(1R,2S)-Norephedrine (500 mg, 3.31 mmol), methyl-4-(5-iodoindazole-1-yl)-benzoate (1.28 g, 3.37 mmol), cesiumcarbonate (2.15 g, 6.61 mmol), copper (I)-iodide (314.9 mg, 1.65 mmol) and butyronitrile (2 mL) are stirred in a glass pressure tube at 120° C. for 20 h. The reaction mixture is filtered via a glass microfibre filter, the solvent evaporated and the residue purified by chromatography (silicagel, eluents: dichloromethane/methanol). 217.9 mg (16.4%) of the title compound are obtained.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07728030B2
출처 데이터셋uspto-grants-2010_06
ORD IDord-a1859bc334c54a22a0996c07c8da5b3b
출처 메모uspto-grants-2010_06